Division of Nephrology and Hypertension

June 28, 2018

Ikizler to succeed Harris as Nephrology and Hypertension director

Jun. 28, 2018—T. Alp Ikizler, MD, an internationally known expert on the nutritional and metabolic aspects of kidney disease, will succeed Raymond Harris, MD, as director of the Department of Medicine’s Division of Nephrology and Hypertension in the Vanderbilt University School of Medicine effective July 1.

By Bill Snyder
March 15, 2018

Research explores barriers to kidney disease screening

New research by Vanderbilt nephrologists highlights potential barriers that may prevent black Americans from being screened for kidney disease.

By VUMC News and Communications
October 13, 2017

New tools to combat kidney fibrosis

Vanderbilt investigators have developed a new mouse model of kidney fibrosis, which provides a platform for identifying new targets and treatment strategies.

By Leigh MacMillan
September 28, 2017

Major grant to enhance kidney disease research

Vanderbilt’s Division of Nephrology and Hypertension has received a five-year, $5 million federal grant to provide core research services in the fight against kidney disease.

By Doug Campbell
September 11, 2017

Vanderbilt, Bayer collaborate to develop new therapies against kidney diseases

Vanderbilt University Medical Center (VUMC) and Bayer have agreed on a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development.

By VUMC News and Communications
August 31, 2017

End-stage kidney disease study seeks to delay dialysis

Vanderbilt University Medical Center (VUMC) is studying the safety of a possible treatment for diabetic kidney disease that would delay or prevent the need for kidney replacement such as dialysis.

By Kathy Whitney
May 11, 2017

EETs contribute to insulin sensitivity

Interventions that increase circulating levels of compounds called EETs may improve insulin sensitivity and treat hypertension.
By Leigh MacMillan
February 2, 2017

New Physician Science Doctoral Program graduates first student

As a fellow in pulmonary and critical care medicine at Vanderbilt University School of Medicine, Bradley Richmond, M.D., saw a lot of patients with chronic obstructive pulmonary disease (COPD), an inflammatory lung disease caused most often by long-term exposure to cigarette smoke.
By Bill Snyder
January 19, 2017

Surprising finding by VU team sheds light on fibrotic disease

Integrins are membrane proteins made up of combinations of different “alpha” and “beta” subunits that enable cells throughout the body to interact with their surroundings.
By Bill Snyder
November 21, 2016

Building the basement membrane

Vanderbilt researchers have discovered steps in the regulation of a key enzyme that builds the basement membrane, a structure that undergirds nearly all animal tissues.
By Bill Snyder
October 20, 2016

Forum celebrates VUMC translational research expertise

Vanderbilt University Medical Center’s vibrant culture of clinical and translational research was celebrated at an annual forum last week, and two physician-scientist leaders were honored with awards.
By Leigh MacMillan
August 30, 2016

VUMC mourns loss of Nephrology’s Schulman

Gerald Schulman, M.D., professor of Medicine, died Aug. 26. He was 65.
By Kathy Whitney
May 12, 2016

Medical societies honor four VUMC physicians

Four physicians from Vanderbilt University Medical Center (VUMC) have been elected to membership in two of the nation’s oldest and most respected medical honor societies — the Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI).
By Bill Snyder
1 … 4 5 6 7 8 9